PTEN and cancer: The PTEN gene was chosen by Moses et al. (31) as the target of the CRISPR/Cas9 system in the SK-MEL-28 melanoma cell line, and it was demonstrated that this repair system is capable of upregulating PTEN and reducing cancer cell migration.